BEYOND: a randomised controlled trial comparing efficacy and safety of individualised follitropin delta dosing in GnRH agonist versus antagonist protocols for first ovarian stimulation cycle

被引:0
|
作者
Sordal, T. [1 ]
Ekerhovd, E. [2 ]
Cohlen, B. [3 ]
Schenk, M. [4 ]
Larsson, P. [5 ]
Lobo, R. [6 ]
Pinton, P. [6 ]
Pinborg, A. [7 ]
机构
[1] Medicus AS, Reprod Med, Trondheim, Norway
[2] Sykehuset Telemark HF, Reprod Med, Telemark, Norway
[3] Isala Fertil Cente, Reprod Med, Overijssel, Netherlands
[4] Das Kinderwunsch Inst Schenk GmbH, Reprod Med, Dobl, Austria
[5] Ferring Pharmaceut, Global Biometr, Kastrup, Denmark
[6] Ferring Pharmaceut, Global Translat & Clin Res & Dev, Kastrup, Denmark
[7] Rigshosp, Fertil Clin, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
O-131
引用
收藏
页数:2
相关论文
共 25 条
  • [21] Pregnancy rates and risk of ovarian hyperstimulation syndrome (OHSS) in a fixed GnRH-antagonist versus GnRH-agonist protocol: randomized controlled trial including 1099 first IVF/ICSI cycles
    Toftager, M.
    Bogstad, J.
    Lossl, K.
    Praetorius, L.
    Zedeler, A.
    Bryndorf, T.
    Nilas, L.
    Pinborg, A.
    HUMAN REPRODUCTION, 2015, 30 : 94 - 95
  • [22] Cumulative live birth rates (CLBR) after first ART cycle including subsequent frozen-thaw cycles in 1050 women attending a randomized trial comparing GnRH-antagonist versus GnRH-agonist protocol
    Toftager, M.
    Bogstad, J.
    Lossl, K.
    Praetorius, L.
    Zedeler, A.
    Bryndorf, T.
    Nilas, L.
    Pinborg, A.
    HUMAN REPRODUCTION, 2016, 31 : 330 - 330
  • [23] A Randomized Controlled Trial on the Efficacy and Safety of Low-Dose hCG in a Short Protocol with GnRH Agonist and Ovarian Stimulation with Recombinant FSH (rFSH) During the Follicular Phase in Infertile Women Undergoing ART
    Siristatidis, Charalampos
    Stavros, Sofoklis
    Dafopoulos, Konstantinos
    Sergentanis, Theodoros
    Domali, Ekaterini
    Drakakis, Peter
    Loutradis, Dimitrios
    REPRODUCTIVE SCIENCES, 2022, 29 (02) : 497 - 505
  • [24] A Randomized Controlled Trial on the Efficacy and Safety of Low-Dose hCG in a Short Protocol with GnRH Agonist and Ovarian Stimulation with Recombinant FSH (rFSH) During the Follicular Phase in Infertile Women Undergoing ART
    Charalampos Siristatidis
    Sofoklis Stavros
    Konstantinos Dafopoulos
    Theodoros Sergentanis
    Ekaterini Domali
    Peter Drakakis
    Dimitrios Loutradis
    Reproductive Sciences, 2022, 29 : 497 - 505
  • [25] Quality of life and psychosocial and physical well-being among 1,023 women during their first assisted reproductive technology treatment: secondary outcome to a randomized controlled trial comparing gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist protocols
    Toftager, Mette
    Sylvest, Randi
    Schmidt, Lone
    Bogstad, Jeanette
    Lossl, Kristine
    Praetorius, Lisbeth
    Zedeler, Anne
    Bryndorf, Thue
    Pinborg, Anja
    FERTILITY AND STERILITY, 2018, 109 (01) : 154 - 164